| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $539K | -31.3% |
| Gross Profit | -$83.5M | -99.6% |
| R&D Expense | $25.2M | -80.9% |
| SG&A Expense | $43.2M | -47.9% |
| Operating Income | -$149.7M | +47.7% |
| Pre-tax Income | -$356.1M | +17.5% |
| Income Tax | -$267K | -345.0% |
| Net Income | -$355.8M | +17.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.1M | +276.4% |
| Accounts Receivable | $0 | -100.0% |
| Inventory | $27.5M | -19.7% |
| Current Assets | $71.9M | -21.3% |
| Total Assets | $425.4M | -19.8% |
| Current Liabilities | $192.7M | -26.2% |
| Total Liabilities | $310.4M | +2.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$70.2M | +74.8% |
| Capital Expenditures | $7.6M | -75.6% |
| Investing Cash Flow | -$7.4M | +76.3% |
| Financing Cash Flow | $80.7M | -72.3% |
| Free Cash Flow | -$77.8M | +74.9% |
| Stockholders' Equity |
| $115.0M |
| -49.6% |